The first workshop of the APAC Lung Cancer Policy Consensus – ASPIRE for Lung Cancer
ASPIRE for Lung Cancer shared a post on LinkedIn:
“Yesterday, on March 18th, ASPIRE successfully concluded the first workshop of the APAC Lung Cancer Policy Consensus initiative, focused on lung cancer prevention, early detection and screening, and diagnosis.
We are pleased to collaborate with Assoc. Prof. Herbert Loong, and Dr. Mary Bussell, in delivering this critical session, convening leading experts from across APAC, including representatives from Hong Kong, China, Indonesia, India, Malaysia, the Philippines, Singapore, Thailand, and Vietnam, as well as global public health and civil society leaders.
During the session, participants engaged in discussions and shared key challenges and successes including:
– Strengthening tobacco control and enforcement through stricter regulations, public awareness, and collaboration across sectors to drive stronger implementation
– Addressing air pollution and environmental risks as key contributors to lung cancer, with a focus on improving policy enforcement and mitigation strategies
– Expanding high-risk screening criteria beyond smoking history to include post-COVID-19 impact, family history, and occupational exposure for more equitable access
– Tackling the rise of alternative tobacco products, such as vaping and chewing tobacco, through targeted policies and behavioural interventions
– Leveraging technology for early detection, including AI-driven screening and optimising access to LDCT through health system-wide programmes
– Enhancing multidisciplinary collaboration between policymakers, healthcare providers, and civil society to improve lung cancer prevention, screening, and treatment outcomes
Building on these discussions, we will develop a set of consensus statements to unite stakeholders in a shared commitment to tackling lung cancer across the region – ensuring no one is left behind.
These statements will also guide further discussions in the second workshop, which will focus on:
– Access to treatment
– Addressing stigma and the patient experience
– Investments and partnerships
As we move toward the second workshop and official launch, we look forward to welcoming more experts from other APAC health systems, further strengthening the breadth and impact of this initiative.
We’d like to thank our participating experts, Asia Pacific Coalition against Lung Cancer, Dr. Aaron Tan, Dr. Chong-Lin Liam, Dr. Frederic Ivan Ting, Dr. Helena Wilcox, Dr. Jemma Arakelyan, Dr. Kenneth Samala, Prof. Martin Chi-Sang Wong, Prof. Pham Cam Phuong, Dr. Sewanti Limaye, Dr. Sita Andarini, A/Prof Thanyanan Reungwetwattana and Prof. Yi-long Wu for their invaluable contributions in Workshop 1.
Let’s continue making progress together!”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023